{"id":"https://openalex.org/W3046464487","doi":"https://doi.org/10.22541/au.159292858.82650822","title":"COVID-19 vaccine-readiness for ocrelizumab and other anti-CD20-depleting therapies in multiple sclerosis and other autoimmune diseases","display_name":"COVID-19 vaccine-readiness for ocrelizumab and other anti-CD20-depleting therapies in multiple sclerosis and other autoimmune diseases","publication_year":2020,"publication_date":"2020-06-23","ids":{"openalex":"https://openalex.org/W3046464487","doi":"https://doi.org/10.22541/au.159292858.82650822","mag":"3046464487"},"language":"en","primary_location":{"id":"doi:10.22541/au.159292858.82650822","doi":"https://doi.org/10.22541/au.159292858.82650822","is_oa":true,"landing_page_url":"https://doi.org/10.22541/au.159292858.82650822","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/au.159292858.82650822","source":null,"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.authorea.com/doi/pdf/10.22541/au.159292858.82650822","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016912802","display_name":"David Baker","orcid":"https://orcid.org/0000-0002-8872-8711","observed_orcids":["https://orcid.org/0000-0002-8872-8711","https://orcid.org/0000-0001-7896-6217"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"David Baker","raw_affiliation_strings":["Queen Mary University of London",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Charles Roberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charles Roberts","raw_affiliation_strings":["Queen Mary University of London",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086639238","display_name":"Gareth Pryce","orcid":"https://orcid.org/0000-0003-0689-5207","observed_orcids":["https://orcid.org/0000-0003-0689-5207"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gareth Pryce","raw_affiliation_strings":["Queen Mary University of London",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014158535","display_name":"Angray S. Kang","orcid":"https://orcid.org/0000-0002-4672-4114","observed_orcids":["https://orcid.org/0000-0002-4672-4114"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["GB","NL"],"is_corresponding":false,"raw_author_name":"Angray Kang","raw_affiliation_strings":["Queen Mary University of London",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom",". Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom","VU medisch centrum School of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":". Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":"VU medisch centrum School of Medical Sciences","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002975609","display_name":"M\u00f3nica Marta","orcid":"https://orcid.org/0000-0002-5464-9070","observed_orcids":["https://orcid.org/0000-0002-5464-9070"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Monica Marta","raw_affiliation_strings":["Queen Mary University of London",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom",". Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":". Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom","institution_ids":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028846946","display_name":"Sa\u00fal Reyes","orcid":"https://orcid.org/0000-0002-3230-3263","observed_orcids":["https://orcid.org/0000-0002-3230-3263"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Saul Reyes","raw_affiliation_strings":["Queen Mary University of London",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom",". Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":". Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom","institution_ids":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057445606","display_name":"Klaus Schmierer","orcid":"https://orcid.org/0000-0002-9293-8893","observed_orcids":["https://orcid.org/0000-0002-9293-8893"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Klaus Schmierer","raw_affiliation_strings":["Queen Mary University of London",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom",". Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":". Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom","institution_ids":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015754502","display_name":"Gavin Giovannoni","orcid":"https://orcid.org/0000-0001-9995-1700","observed_orcids":["https://orcid.org/0000-0001-9995-1700"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gavin Giovannoni","raw_affiliation_strings":["Queen Mary University of London",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom",". Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":". Clinical Board: Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom","institution_ids":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033448398","display_name":"Sandra Amor","orcid":"https://orcid.org/0000-0001-6169-9845","observed_orcids":["https://orcid.org/0000-0001-6169-9845"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["GB","NL"],"is_corresponding":false,"raw_author_name":"Sandra Amor","raw_affiliation_strings":["VU medisch centrum School of Medical Sciences",". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom",". Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom",".Pathology Department, Amsterdam UMC, VUmc site, Amsterdam, The Netherlands","Queen Mary University of London"],"raw_orcid":"https://orcid.org/0000-0001-6169-9845","affiliations":[{"raw_affiliation_string":"VU medisch centrum School of Medical Sciences","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":". Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":". Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":".Pathology Department, Amsterdam UMC, VUmc site, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5016912802"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.21789999306201935,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19-vaccine-response","display_name":"COVID-19 vaccine response","score":0.7979999780654907},{"id":"https://openalex.org/keywords/ocrelizumab","display_name":"ocrelizumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8410000205039978},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9240000247955322},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.7929999828338623},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.9179999828338623},{"id":"https://openalex.org/keywords/b-cell-reconstitution","display_name":"B cell reconstitution","score":0.7749999761581421},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.8330000042915344},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.7509999871253967},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.8209999799728394},{"id":"https://openalex.org/keywords/dose-interruption","display_name":"dose interruption","score":0.7120000123977661},{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":0.6629999876022339},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.8297182321548462},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7930472493171692},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.7507442235946655},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.71540766954422},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6640115976333618},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.5518273115158081},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.4964292645454407},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.46716225147247314},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.45952802896499634},{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.4138891398906708},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3352885842323303}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22541/au.159292858.82650822","doi":"https://doi.org/10.22541/au.159292858.82650822","is_oa":true,"landing_page_url":"https://doi.org/10.22541/au.159292858.82650822","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/au.159292858.82650822","source":null,"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.22541/au.159292858.82650822","doi":"https://doi.org/10.22541/au.159292858.82650822","is_oa":true,"landing_page_url":"https://doi.org/10.22541/au.159292858.82650822","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/au.159292858.82650822","source":null,"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320312269","display_name":"Ironwood Pharmaceuticals, Incorporated","ror":"https://ror.org/05v86fk30"},{"id":"https://openalex.org/F4320312517","display_name":"Vertex Pharmaceuticals","ror":"https://ror.org/00anb1726"},{"id":"https://openalex.org/F4320314782","display_name":"GW Pharmaceuticals","ror":"https://ror.org/01gtctx88"},{"id":"https://openalex.org/F4320315720","display_name":"Five Prime Therapeutics","ror":"https://ror.org/001ms2r47"},{"id":"https://openalex.org/F4320315887","display_name":"GlaxoSmithKline Japan","ror":"https://ror.org/01j6sxy67"},{"id":"https://openalex.org/F4320316469","display_name":"Atara Biotherapeutics","ror":"https://ror.org/04h82wq77"},{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320333587","display_name":"Sanofi Genzyme","ror":null},{"id":"https://openalex.org/F4320337846","display_name":"UCB Pharma","ror":"https://ror.org/01n029866"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3046464487.pdf","grobid_xml":"https://content.openalex.org/works/W3046464487.grobid-xml"},"referenced_works_count":101,"referenced_works":["https://openalex.org/W1951218190","https://openalex.org/W1984099739","https://openalex.org/W2004583429","https://openalex.org/W2011342000","https://openalex.org/W2020206181","https://openalex.org/W2042927558","https://openalex.org/W2067071280","https://openalex.org/W2077286174","https://openalex.org/W2093556537","https://openalex.org/W2124598981","https://openalex.org/W2126336004","https://openalex.org/W2130342500","https://openalex.org/W2132204826","https://openalex.org/W2135564056","https://openalex.org/W2142184993","https://openalex.org/W2151461700","https://openalex.org/W2292472819","https://openalex.org/W2584413859","https://openalex.org/W2594563663","https://openalex.org/W2625522638","https://openalex.org/W2626464574","https://openalex.org/W2768964978","https://openalex.org/W2784795832","https://openalex.org/W2805441800","https://openalex.org/W2823433919","https://openalex.org/W2888766333","https://openalex.org/W2889885328","https://openalex.org/W2890733939","https://openalex.org/W2908395900","https://openalex.org/W2909545308","https://openalex.org/W2914053307","https://openalex.org/W2914770914","https://openalex.org/W2954141460","https://openalex.org/W2977883158","https://openalex.org/W2982234260","https://openalex.org/W3001118548","https://openalex.org/W3003957694","https://openalex.org/W3011047976","https://openalex.org/W3013987649","https://openalex.org/W3014170141","https://openalex.org/W3014441189","https://openalex.org/W3014449062","https://openalex.org/W3014972620","https://openalex.org/W3015371627","https://openalex.org/W3015662129","https://openalex.org/W3016123694","https://openalex.org/W3016322638","https://openalex.org/W3016611530","https://openalex.org/W3016673289","https://openalex.org/W3016880822","https://openalex.org/W3018072231","https://openalex.org/W3018773626","https://openalex.org/W3018910405","https://openalex.org/W3019225579","https://openalex.org/W3019337088","https://openalex.org/W3019642755","https://openalex.org/W3019834697","https://openalex.org/W3020062806","https://openalex.org/W3021880084","https://openalex.org/W3022375169","https://openalex.org/W3022631642","https://openalex.org/W3022913130","https://openalex.org/W3023013216","https://openalex.org/W3023488256","https://openalex.org/W3023558422","https://openalex.org/W3023561439","https://openalex.org/W3023996322","https://openalex.org/W3024016727","https://openalex.org/W3024105190","https://openalex.org/W3024448878","https://openalex.org/W3025063739","https://openalex.org/W3025320502","https://openalex.org/W3025715263","https://openalex.org/W3025939368","https://openalex.org/W3026558549","https://openalex.org/W3027041200","https://openalex.org/W3027138240","https://openalex.org/W3027204812","https://openalex.org/W3027918021","https://openalex.org/W3028946590","https://openalex.org/W3029126015","https://openalex.org/W3029453939","https://openalex.org/W3031196929","https://openalex.org/W3033022675","https://openalex.org/W3033315606","https://openalex.org/W3034107318","https://openalex.org/W3034241043","https://openalex.org/W3034543271","https://openalex.org/W3034725616","https://openalex.org/W3042062103","https://openalex.org/W3089196337","https://openalex.org/W3093239501","https://openalex.org/W3096867322","https://openalex.org/W3100347672","https://openalex.org/W3135671690","https://openalex.org/W3148143574","https://openalex.org/W4389447149","https://openalex.org/W6608580216","https://openalex.org/W6776346925","https://openalex.org/W6776956538","https://openalex.org/W7074158452"],"related_works":["https://openalex.org/W3043294634","https://openalex.org/W3092836541","https://openalex.org/W3199091389","https://openalex.org/W3201601622","https://openalex.org/W4200070788","https://openalex.org/W3036483899","https://openalex.org/W4380990787","https://openalex.org/W3133786183","https://openalex.org/W4389427820","https://openalex.org/W3016673289"],"abstract_inverted_index":{"Although":[0],"most":[1],"autoimmune":[2,227],"diseases":[3],"are":[4,140,180],"considered":[5],"to":[6,14,72,105,142,182,215,218],"be":[7,183,213],"CD4":[8,22],"T-cell":[9,137],"or":[10,74],"antibody-mediated,":[11],"many":[12],"respond":[13],"CD20-depleting":[15],"antibodies":[16],"that":[17,29,96,124,210],"have":[18,172],"limited":[19],"influence":[20,133],"on":[21,82,190],"and":[23,36,55,85,91,116,128,135,148,177,193,199,225,236],"plasma":[24],"cells.":[25],"This":[26,154,208],"includes":[27],"rituximab":[28,198],"is":[30,50,57,155,241],"used":[31],"in":[32,38,51,69,77,223],"cancer,":[33],"rheumatoid":[34],"arthritis":[35],"off-label":[37],"a":[39,75],"large":[40],"number":[41],"of":[42,88,164],"other":[43,129,226],"autoimmunities,":[44,130],"notably":[45],"multiple":[46,89,126,170],"sclerosis,":[47],"where":[48],"ofatumumab":[49],"late":[52],"stage":[53],"development":[54],"ocrelizumab":[56,201],"approved":[58],"for":[59],"use.":[60],"Recently,":[61],"the":[62,83,146,159],"COVID-19":[63],"pandemic":[64],"created":[65],"concerns":[66],"about":[67],"immunosuppression":[68],"autoimmunity,":[70],"leading":[71],"cessation":[73],"delay":[76],"immunotherapy":[78],"treatments.":[79],"However,":[80,174],"based":[81,189],"known":[84],"emerging":[86],"biology":[87],"sclerosis":[90,127,171],"COVID-19,":[92],"it":[93,109,211],"was":[94],"hypothesised":[95],"whilst":[97,229],"B-cell":[98,121,191],"depletion":[99],"should":[100],"not":[101,132],"necessarily":[102],"expose":[103],"people":[104,168],"severe":[106,152],"SARS-CoV-2-related":[107],"issues,":[108],"may":[110,212],"inhibit":[111],"protective":[112,175],"immunity":[113],"following":[114],"infection":[115],"vaccination.":[117],"As":[118],"such,":[119],"drug-induced":[120],"subset":[122],"inhibition":[123],"controls":[125],"would":[131],"innate":[134,149],"CD8":[136],"responses,":[138,195],"which":[139],"central":[141],"SARS-CoV-2":[143,165],"elimination,":[144],"nor":[145],"hyper-coagulation":[147],"inflammation":[150],"causing":[151],"morbidity.":[153],"supported":[156],"clinically,":[157],"as":[158],"majority":[160],"(mortality":[161],"rate":[162],"n=~5/392)":[163],"infected,":[166],"CD20-depleted":[167],"with":[169],"recovered.":[173],"neutralising-antibody":[176],"vaccination":[178,194,232],"responses":[179],"predicted":[181],"blunted,":[184],"until":[185],"na\u00efve":[186],"B-cells":[187],"repopulate,":[188],"repopulation-kinetics":[192],"from":[196],"published":[197],"unpublished":[200],"(NCT00676715,":[202],"NCT02545868)":[203],"trial":[204],"data,":[205],"shown":[206],"here.":[207],"suggests":[209],"possible":[214],"undertake":[216],"dose-interruption":[217],"maintain":[219],"inflammatory":[220],"disease":[221],"control":[222],"MS":[224],"diseases,":[228],"allowing":[230],"effective":[231,239],"against":[233],"SARS-CoV-29,":[234],"if":[235],"when":[237],"an":[238],"vaccine":[240],"available.":[242]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2020-08-07T00:00:00"}